Advertisement
Screener

Acorda Therapeutics, Inc. Depreciation

Acorda Therapeutics, Inc. Depreciation

Acorda Therapeutics, Inc. reported Depreciation of $1.50 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.

Discontinued › Cash Flow › Operating Activities

us-gaap:Depreciation · last filed 2012-02-28

  • Acorda Therapeutics, Inc. depreciation for fiscal 2011 was $1.50M, a 36.36% increase from fiscal 2010.
  • Acorda Therapeutics, Inc. depreciation for fiscal 2010 was $1.10M.
Period endDepreciation 12 month
2011-12-31$1.50M
10-K · filed 2012-02-28
2010-12-31$1.10M
10-K · filed 2012-02-28